PHARMAKON ENGINEERING ApS: Financial statements 2015
CVR: 35248714
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
PHARMAKON ENGINEERING ApS (CVR 35248714) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -5,450 and a net result of DKK -5,450. Equity in the 2015 report amounted to DKK 44,600. The solvency ratio was 91%.
- Gross Profit
- DKK -5,450
- Profit/Loss
- DKK -5,450
- Equity
- DKK 44,600
- Total Assets
- DKK 49,017
Official annual report
How creditworthy is PHARMAKON ENGINEERING ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PHARMAKON ENGINEERING ApS has published its interim report for the period May 16, 2013 to June 30, 2014.
As of March 26, 2015, Misbah Malik Abbas is registered as director of PHARMAKON ENGINEERING ApS.
As of March 26, 2015, Henrik Bernt Sanders has stepped down as liquidator of PHARMAKON ENGINEERING ApS.
On March 26, 2015, PHARMAKON ENGINEERING ApS exited liquidation.
As of March 9, 2015, Henrik Bernt Sanders is registered as liquidator of PHARMAKON ENGINEERING ApS.
On March 9, 2015, PHARMAKON ENGINEERING ApS entered liquidation.
As of February 2, 2015, Misbah Malik Abbas has stepped down as director of PHARMAKON ENGINEERING ApS.
About PHARMAKON ENGINEERING ApS
PHARMAKON ENGINEERING ApS was a Danish company of the type Anpartsselskab based in Gentofte, founded in 2013. The company has been dissolved on 28 November 2017. The company was registered under the industry Rådgivende ingeniørvirksomhed inden for produktions- og maskinteknik. The company has 0 employees (2014). In 2016, the company reported a net result of DKK 0 compared with DKK -5,450 the year before. Equity in the 2016 report amounted to DKK 44,600.